$151.720
-5.113 (-3.37%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BLTE Prediction & Forecast by Similar Chart Analysis
Alphio's BLTE stock price prediction model matches the current Belite Bio, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $147.59 (-2.72%). The 1-week path is $152.24 (+0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Belite Bio, Inc Stock?
Belite Bio Inc is currently a hold. The stock is trading at $151.72, down 5.80% over the last five days, with a 1-year change of +132.13%. The RSI is at 27.79, indicating it is oversold, which could suggest a potential rebound. However, the forward P/E ratio is extremely high at 227.27, reflecting significant investor caution regarding future earnings. The main risk is the ongoing net losses, which reached $28.4 million in Q2 2026, indicating financial instability despite positive developments like FDA Priority Review for Tinlarabant.
BLTE stock price ended at $151.72 on Friday, after losing -3.37%
Belite Bio, Inc (BLTE) last closed at $151.72, losing -3.37%. These facts feed the 1-day and 1-week BLTE price prediction above.
Forecast Drivers
Belite Bio, Inc (BLTE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BLTE, ranked by similarity.
Seasonality analysis for BLTE
Historically the probability of a positive August return for BLTE is 77.78%. October offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BLTE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $53.62 | $58.33 | $69.22 | -61.55% |
| Sep 2026 | $48.42 | $57.62 | $60.82 | -62.02% |
| Oct 2026 | $65.23 | $70.88 | $78.93 | -53.28% |
| Nov 2026 | $62.14 | $63.40 | $63.95 | -58.22% |
| Dec 2026 | $65.08 | $68.82 | $77.60 | -54.64% |
In 2026, Belite Bio, Inc (BLTE) is projected to range from $48.42 to $78.93.
Belite Bio, Inc 2026 monthly forecast
In Aug 2026, Belite Bio, Inc is projected to average $58.33, with a low of $53.62 and high of $69.22.
In Sep 2026, Belite Bio, Inc is projected to average $57.62, with a low of $48.42 and high of $60.82.
In Oct 2026, Belite Bio, Inc is projected to average $70.88, with a low of $65.23 and high of $78.93.
In Nov 2026, Belite Bio, Inc is projected to average $63.40, with a low of $62.14 and high of $63.95.
In Dec 2026, Belite Bio, Inc is projected to average $68.82, with a low of $65.08 and high of $77.60.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.